306 related articles for article (PubMed ID: 21328342)
1. Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth.
Tazzyman S; Barry ST; Ashton S; Wood P; Blakey D; Lewis CE; Murdoch C
Int J Cancer; 2011 Aug; 129(4):847-58. PubMed ID: 21328342
[TBL] [Abstract][Full Text] [Related]
2. CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β.
Jablonska J; Wu CF; Andzinski L; Leschner S; Weiss S
Int J Cancer; 2014 Mar; 134(6):1346-58. PubMed ID: 24154944
[TBL] [Abstract][Full Text] [Related]
3. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
[TBL] [Abstract][Full Text] [Related]
4. CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.
Braber S; Overbeek SA; Koelink PJ; Henricks PA; Zaman GJ; Garssen J; Kraneveld AD; Folkerts G
Eur J Pharmacol; 2011 Oct; 668(3):443-9. PubMed ID: 21458445
[TBL] [Abstract][Full Text] [Related]
5. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
6. A synthetic, non-peptide CXCR2 antagonist blocks MIP-2-induced neutrophil migration in mice.
Matzer SP; Zombou J; Sarau HM; Röllinghoff M; Beuscher HU
Immunobiology; 2004; 209(3):225-33. PubMed ID: 15518334
[TBL] [Abstract][Full Text] [Related]
7. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
8. Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin.
Cheng Y; Mo F; Li Q; Han X; Shi H; Chen S; Wei Y; Wei X
Mol Cancer; 2021 Apr; 20(1):62. PubMed ID: 33814009
[TBL] [Abstract][Full Text] [Related]
9. Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment.
Kemp DM; Pidich A; Larijani M; Jonas R; Lash E; Sato T; Terai M; De Pizzol M; Allegretti M; Igoucheva O; Alexeev V
Oncotarget; 2017 Feb; 8(9):14428-14442. PubMed ID: 28129639
[TBL] [Abstract][Full Text] [Related]
10. Alkali-induced corneal neovascularization is independent of CXCR2-mediated neutrophil infiltration.
Lu P; Li L; Mukaida N; Zhang X
Cornea; 2007 Feb; 26(2):199-206. PubMed ID: 17251813
[TBL] [Abstract][Full Text] [Related]
11. CXCR2/CXCR2 ligand biological axis impairs alveologenesis during dsRNA-induced lung inflammation in mice.
Londhe VA; Belperio JA; Keane MP; Burdick MD; Xue YY; Strieter RM
Pediatr Res; 2005 Nov; 58(5):919-26. PubMed ID: 16183824
[TBL] [Abstract][Full Text] [Related]
12. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
[TBL] [Abstract][Full Text] [Related]
13. CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo.
Zhang XW; Liu Q; Wang Y; Thorlacius H
Br J Pharmacol; 2001 Jun; 133(3):413-21. PubMed ID: 11375258
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin antagonizes CD40L secretion, CXC chemokine formation, and pulmonary infiltration of neutrophils in abdominal sepsis.
Zhang S; Rahman M; Zhang S; Qi Z; Thorlacius H
J Leukoc Biol; 2011 May; 89(5):735-42. PubMed ID: 21330348
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2.
Kaur M; Singh D
J Pharmacol Exp Ther; 2013 Oct; 347(1):173-80. PubMed ID: 23912333
[TBL] [Abstract][Full Text] [Related]
16. Facilitation of Allergic Sensitization and Allergic Airway Inflammation by Pollen-Induced Innate Neutrophil Recruitment.
Hosoki K; Aguilera-Aguirre L; Brasier AR; Kurosky A; Boldogh I; Sur S
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):81-90. PubMed ID: 26086549
[TBL] [Abstract][Full Text] [Related]
17. Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase.
Gong L; Cumpian AM; Caetano MS; Ochoa CE; De la Garza MM; Lapid DJ; Mirabolfathinejad SG; Dickey BF; Zhou Q; Moghaddam SJ
Mol Cancer; 2013 Dec; 12(1):154. PubMed ID: 24321240
[TBL] [Abstract][Full Text] [Related]
18. IL-17-CXC Chemokine Receptor 2 Axis Facilitates Breast Cancer Progression by Up-Regulating Neutrophil Recruitment.
Wu L; Awaji M; Saxena S; Varney ML; Sharma B; Singh RK
Am J Pathol; 2020 Jan; 190(1):222-233. PubMed ID: 31654638
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis.
Farooq SM; Stillie R; Svensson M; Svanborg C; Strieter RM; Stadnyk AW
J Pharmacol Exp Ther; 2009 Apr; 329(1):123-9. PubMed ID: 19131582
[TBL] [Abstract][Full Text] [Related]
20. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
